QUANTIFY RESEARCH is a global partner to the pharmaceutical industry in close partnership with academia, patients, public institutions & clinical experts.

Press

20Jan 2023

Societal economic burden and determinants of costs for atopic dermatitis

Atopic dermatitis is a common inflammatory disease but the economic burden of is not well understood. In one of our most recent publications, Quantify authors; Gustaf OrtsäterAlexander Rieem Dun and Kirk Geale showed that atopic dermatitis was associated with a significant societal economic burden.

The burden of AD was mainly driven by increased direct healthcare costs, but indirect costs including parental leave to care for a sick child […]

16Jan 2023

Power BI demo

Have you seen our new demo, demonstrating our capabilities in Power BI? Power BI is an excellent tool designed to make complex data such as register-based RWE more accessible to broader audiences, allowing for instant analysis and insights designed for your needs.

Contact us at info@quantifyresearch.com if you want to know more!
https://lnkd.in/dbTGqTN3

12Jan 2023

Quantify published 8 papers based on cross-Nordic RWE studies in 2022! ?

A “cross-Nordic RWE study” includes an analysis of data from multiple Nordic countries. In 2022, Quantify published 8 papers, based on EMPRISE, BISCUITS, NORDSTAR and the ATTR-CM study, providing important evidence on Nordic-wide comparative effectiveness, treatment patterns and unmet needs, in various disease areas. In contrast to single country studies, cross-Nordic research provides better generalizability and can identify important Nordic differences in routine clinical care, in addition to increasing […]